SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-012443
Filing Date
2024-04-18
Accepted
2024-04-18 16:22:57
Documents
14
Period of Report
2024-04-15
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eton20240412_8k.htm   iXBRL 8-K 25235
  Complete submission text file 0001437749-24-012443.txt   156646

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eton-20240415.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eton-20240415_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eton-20240415_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eton-20240415_pre.xml EX-101.PRE 11584
17 EXTRACTED XBRL INSTANCE DOCUMENT eton20240412_8k_htm.xml XML 2844
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38738 | Film No.: 24854583
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)